Ticker

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical will be conducting a Non-Deal Roadshow (NDR) and participating in several investor conferences throughout September 2026.

SBC Medical Group NASDAQ: SBC said its growth re-accelerated in the second quarter of 2026 following structural reforms undertaken in 2025, with profit growth exceeding revenue growth as the company expanded management services revenue and increased service fees.

NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research quarterly update on SBC Medical Group Holdings Incorporated (NASDAQ:SBC), which, together with its subsidiaries, provides management services to cosmetic treatment centers via a franchise model in Japan, Vietnam, Thailand, Singapore,…

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2026 / Emerging Growth Research today announced the release of its Q2:26 Quarterly Update Report on SBC Medical Group Holdings (NASDAQ:SBC), reiterating its Buy rating and increasing its 12-month price target to $11.00 from $10.00. The Quarterly Update highlights SBC Medical Group's return to revenue growth in 2026 following the completion of pricing-related headwinds…

SBC Medical Group NASDAQ: SBC said its growth re-accelerated in the second quarter of 2026 as the company completed structural reforms undertaken in 2025, expanded its clinic network and increased management-services revenue.